Dimethylacetamide-induced Hepatic Injury in Vitro: Mechanism and Potential Preventive Strategy.

Ming Liu,Xin,Minglun Gong,Hsi-Hsien Wei,Bin Xu,Victoria C. Yan,Qiong,Wanxue Zhu,Bao,Qing Li
DOI: https://doi.org/10.3967/bes2016.018
2016-01-01
Abstract:N,N-Dimethylacetamide (DMAc) is a widely used organic solvent in modern chemical industry with low to moderate hepatotoxicity to occupational health of employees. But so far, there are fewer and less conclusive data concerning its pathogenic mechanism in detail. In current study, the toxicity of DMAc was firstly investigated on human normal hepatocytes (LO-2), using a series of molecular biology measurements to ananlyze the effect and mechanism of DMAc-induced hepatic cell injury and explore effective prophylactic measures. We found that DMAc triggered LO-2 apoptosis in a obviously dose-dependent manner, caused by increased ROS generation and activation of Bcl-2 pathway. Significantly, glutathione (GSH) rather than vitamin C (Vit C) could partially inhibit DMAc-induced apoptosis thus showing potential as a effective precaution for workers.
What problem does this paper attempt to address?